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Supplementary Fig. 1 
 
 
 
All  Cascade  subunits  are  required  for  immunity.  The  efficiency  of  plaquing  (EOP)  was 
determined in E. coli BL21-AI containing complete Cascade, phage λ-targetting T1-4 CRISPR 
(see Supplementary  Fig. 2) and Cas3
1, and for  strains expressing Cascade sub-complexes 
lacking one of the Cas proteins. Host strain E. coli BL21-AI does not contain cas-genes
2. 
Error bars indicate one standard deviation. 
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Supplementary Fig. 2 
 
 
 
CRISPRs  used  in  this  study.  (a)  Phage  l  genome  map  indicating  the  main  genes  and 
transcripts (dotted arrows), and the positions of the protospacers on the coding or template 
strand. (b) Schematic overview of CRISPRs used in this study (repeats: diamonds, spacers: 
rectangles). The N CRISPR was designed as a non-targeting control containing the naturally 
occurring spacers 1, 3, 5, and 7 from E. coli K12, which have no homology to any known 
phage
1. The number of plaque forming units obtained in the presence of this CRISPR was 
used to calculate the efficiency of plaquing (Supplementary Fig. 1). The uniform CRISPR 
R44 was designed based on a natural spacer at the second position of the CRISPR in E. coli 
R44 (ECOR44)
3,4. This spacer was derived from the upfA gene of phage P1 and P7. The R44 
CRISPR was designed such that the spacer was repeated seven times. The sequences of the 
CRISPRs are provided below. 
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K12 CRISPR, pWUR396 
GCGTACCATGGCATAAGGAAATGTTACATTAAGGTTGGTGGGTTGTTTTTATGGGAAAAAATGCTTTAAGAACAA
ATGTATACTTTTAGAGAGTTCCCCGCGCCAGCGGGGATAAACCGCTTTCGCAGACGCGCGGCGATACGCTCACGC
AGAGTTCCCCGCGCCAGCGGGGATAAACCGCAGCCGAAGCCAAAGGTGATGCCGAACACGCTGAGTTCCCCGCGC
CAGCGGGGATAAACCGGGCTCCCTGTCGGTTGTAATTGATAATGTTGAGAGTTCCCCGCGCCAGCGGGGATAAAC
CGTTTGGATCGGGTCTGGAATTTCTGAGCGGTCGCGAGTTCCCCGCGCCAGCGGGGATAAACCGCGAATCGCGCA
TACCCTGCGCGTCGCCGCCTGCGAGTTCCCCGCGCCAGCGGGGATAAACCGTCAGCTTTATAAATCCGGAGATAC
GGAAACTAGAGTTCCCCGCGCCAGCGGGGATAAACCGGACTCACCCCGAAAGAGATTGCCAGCCAGCTTGAGTTC
CCCGCGCCAGCGGGGATAAACCGCTGCTGGAGCTGGCTGCAAGGCAAGCCGCCCAGAGTTCCCCGCGCCAGCGGG
GATAAACCGGGGGGCGCATGACCGTAAACATTATCCCCCGGGAGTTCCCCGCGCCAGCGGGGATAAACCGGGAGT
TCAGACATAGGTGGAATGATGGACTACGAGTTCCCCGCGTTAGCGGGGATAAACCGCCCGGTAGCCAGGTTTGCA
ACGCCTGAACCGAGAGTTCCCCGCGCCAGCAGGGATAAACCGGCAACGACGGTGAGATTTCACGCCTGACGCTGG
GTACCGGACC 
 
Non-targeting CRISPR (N), pWUR477 
GGCGCGCCATGGAAACAAAGAATTAGCTGATCTTTAATAATAAGGAAATGTTACATTAAGGTTGGTGGGTTGTTT
TTATGGGAAAAAATGCTTTAAGAACAAATGTATACTTTTAGAGAGTTCCCCGCGCCAGCGGGGATAAACCGCTTT
CGCAGACGCGCGGCGATACGCTCACGCAGAGTTCCCCGCGCCAGCGGGGATAAACCGCAGCCGAAGCCAAAGAAT
TCGCCGAACACGCTGAGTTCCCCGCGCCAGCGGGGATAAACCGGGCTCCCTGTCGGTTGTAATTGATAATGTTGA
GAGTTCCCCGCGCCAGCGGGGATAAACCGTTTGGATCGGGTCTGGATCCTCTGAGCGGTCGGAGTTCCCCGCGCC
AGCGGGGATAAACCGCGAATCGCGCATACCCTGCGCGTCGCCGCCTGGAGTTCCCCGCGCCAGCGGGGATAAACC
GTCAGCTTTATAAATATGCATATACGGAAACTAGAGTTCCCCGCGCCAGCGGGGATAAACCGGACTCACCCCGAA
AGAGATTGCCAGCCAGCTTGAGTTCCCCGCGCCAGCGGGGATAAACCGCAGCTCCCATTTTCAAACCCATCAAGA
CGCGGTACCTTAATTAA 
 
Template CRISPR (T1-4), pWUR478 
GGCGCGCCATGGAAACAAAGAATTAGCTGATCTTTAATAATAAGGAAATGTTACATTAAGGTTGGTGGGTTGTTT
TTATGGGAAAAAATGCTTTAAGAACAAATGTATACTTTTAGAGAGTTCCCCGCGCCAGCGGGGATAAACCGCTGA
GTGTGATCGATGCCATCAGCGAAGGGCCGAGTTCCCCGCGCCAGCGGGGATAAACCGCAGCCGAAGCCAAAGAAT
TCGCCGAACACGCTGAGTTCCCCGCGCCAGCGGGGATAAACCGCAAGCAACAGGCAGGCGTGACAGCCAGCAAAC
GAGTTCCCCGCGCCAGCGGGGATAAACCGTTTGGATCGGGTCTGGATCCTCTGAGCGGTCGGAGTTCCCCGCGCC
AGCGGGGATAAACCGTGGGATGCCTACCGCAAGCAGCTTGGCCTGAAGAGTTCCCCGCGCCAGCGGGGATAAACC
GTCAGCTTTATAAATATGCATATACGGAAACTAGAGTTCCCCGCGCCAGCGGGGATAAACCGTGACAAGTCCACG
TATGACCCGACCGACGATAGAGTTCCCCGCGCCAGCGGGGATAAACCGCAGCTCCCATTTTCAAACCCATCAAGA
CGCGGTACCTTAATTAA 
 
ECOR44-1.2 (7x), pWUR547 
CCTGCATTAGGTAATACGACTCACTATAGGATAAACCGACGGTATTGTTCAGATCCTGGCTTGCCAACAGGAGTT
CCCCGCGCCAGCGGGGATAAACCGACGGTATTGTTCAGATCCTGGCTTGCCAACAGGAGTTCCCCGCGCCAGCGG
GGATAAACCGACGGTATTGTTCAGATCCTGGCTTGCCAACAGGAGTTCCCCGCGCCAGCGGGGATAAACCGACGG
TATTGTTCAGATCCTGGCTTGCCAACAGGAGTTCCCCGCGCCAGCGGGGATAAACCGACGGTATTGTTCAGATCC
TGGCTTGCCAACAGGAGTTCCCCGCGCCAGCGGGGATAAACCGACGGTATTGTTCAGATCCTGGCTTGCCAACAG
GAGTTCCCCGCGCCAGCGGGGATAAACCGACGGTATTGTTCAGATCCTGGCTTGCCAACAGGAGTTCCCCGCGCC
AGCGGGGATAAACCGGGTACC 
Nature Structural & Molecular Biology: doi:10.1038/nsmb.2019 
 
Supplementary Fig. 3 
 
a 
 
5’ OH – AUAAACCGACGGUAUUGUUCAGAUCCUGGCUUGCCAACAGGAGUUCCCCGCGCCAGCGGGG – 2’, 3’-P 
 
b 
 
 
c 
Sequence  Position  Theoretical mass (Da) 
Experimental mass 
(Da) 
AUAAACCGp  A1:G8  2596.597  2596.2 
ACGp  A9:G11  997.617  997.1 
UAUUGp  U13:G17  1610.94  1610.1 
UUCAGp  U18:G22  1609.955  1609.3 
AUCCUGp  A23:G28  1915.139  1914.9 
CUUGp  C30:G33  1280.745  1280.2 
CCAACAGp  C34:G40  2266.403  2266.1 
AGp  A42:G43  692.433  692.1 
UUCCCCGp  U44:G50  2196.298  2195.3 
CCAGp  C53:G56  1302.801  1302.3 
 
d 
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e 
Sequence  Position  Theoretical mass (Da) 
Experimental mass 
(Da) 
AUp  A1:U2 / A14:U15  653.393  653.1 
AAACp  A3:C6  1310.826  1310.4 
GACp / AGCp  G8:C10 / A55:C57  997.617  997.1 
GGUp  G11:U13  1014.602  1014.2 
GUp  G17:U18  669.393  669.0 
AGAUp  A21:U24  1327.811  1327.3 
GGCp  G28:C30  1013.617  1013.4 
AACp  A36:C38  981.617  981.2 
AGGAGUp  A39:U44  2018.229  2017.7 
GGGGp  G58:G61  1398.851  1398.4 
GGGG^p  G58:G61  1380.836  1380.4 
 
RNase digests of the crRNA. (a) Sequence of mature crRNA with the R44 spacer sequence 
shaded, and the hairpin underlined. (b) Base peak chromatogram of the RNaseT1 digest of 
mature crRNA. The predominant oligoribonucleotide peaks assigned to the mature crRNA are 
highlighted. (c) Summary of the identified oligoribonucleotides assigned to mature crRNA 
from  the  RNaseT1  digest.  (d)  Base  peak  chromatogram  of  the  RNaseA  digest  of  mature 
crRNA.  The  predominant  oligoribonucleotide  peaks  assigned  to  the  mature  crRNA  are 
highlighted. (e) Summary of the identified oligoribonucleotides assigned to mature crRNA 
from the RNaseA digest. ^ indicates cyclic 2’,3’-phosphate. It is worth mentioning that the 
cyclic phosphate 3’-end is not a substrate for E. coli poly(A) RNA polymerase
5, and this 
explains why only shorter, apparently partly degraded crRNAs were cloned and sequenced 
previously
1. 
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Supplementary Fig. 4 
 
 
 
 
Native  PAGE  of  Cascade-target  DNA  complexes.  Coomassie-blue  stained  native  PAGE 
analysis of Cascade and sub-complexes binding ssDNA oligonucleotides complementary to 
the R44 crRNA (BG3028, see Table S3). The gel shows the increased migration rates of 
Cascade complexes loaded with uniform R44 crRNA in the presence their complementary 
target ssDNA due to the additional charge negative charge of the ssDNA. By contrast, the 
migration  rate  of  Cascade  loaded  with  different  crRNAs  derived  from  the  E.  coli  K12 
CRISPR I array that does not contain the R44 spacer is not affected. In addition, differences 
in migration rates of the various complexes (Cascade, CasBCDE and CasCDE) are visible.  
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Supplementary Fig. 5 
 
 
 
CasA complementation of non-specific DNA binding. Binding ability of uniform crRNA-
loaded  (R44)  Cascade,  CasBCDE  +  CasA,  CasBCDE  and  CasA  to  non-target  ssDNA  is 
shown. While CasA does not exhibit non-specific DNA binding on by itself, it is able to 
restore the non-specific DNA binding of CasBCDE. 
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Supplementary Fig. 6 
 
 
 
(a)  Native  mass  spectrum  of  Cascade  after  treatment  with  HRV3C  protease.  A  dominant 
species with a mass of 401,279 Da (blue triangle) was observed, confirming the presence of 
two copies of CasB in the intact assembly. Indicated by the green triangles is the complex 
lacking CasA. (b) Tandem mass spectrum of the 42+ ion of Cascade. Besides the dissociation 
of  CasA  (green)  also  CasC  (orange)  dissociated  from  the  complex.  The  complex  lacking 
CasA further expels a CasC subunit to form a 310 kDa Cascade sub-complex (blue). The low 
m/z  region  of  the  spectrum  shows  the  dissociated  CasA,  CasC  and  CasD  proteins. 
Overlapping peaks of two different complexes are indicated by two colors. (c) Native mass 
spectrum  of  Cascade  bound  to  the  ssDNA-probe.  The  mass  of  the  complex  increased  by 
10,201 Da, indicating the presence of one crRNA per Cascade. The inset shows the same 
spectrum after energetically activating the Cascade-ssDNA probe complex. The charge state 
distribution for the ssDNA probe is centered around 2,000 m/z. 
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Supplementary Fig. 7 
 
a     Cascade (1,231, 42,098, 3)  b     Cascade-DNA (627, 24,579, 6) 
   
 
c     CasBCDE-DNA  (1,009, 43,694, 3) 
 
d     CasBCDE (773, 26,665, 1) 
   
 
e     CasCDE (544, 10,855, 1) 
 
 
 
 
(a-e)  Raw  Electron  Micrographs  of  Cascade,  CasBCDE  and  CasCDE  preparations  in  the 
presence or absence of target ssDNA. The number of raw micrographs used to generate the 
class averages in Fig. 6, the total number of particles analysed, and the number of particle 
classes are shown in brackets, respectively. The scale bar represents 100 nm. 
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Supplementary Fig. 8 
 
a 
 
 
 
                               b      c 
 
 
(a) Single particle EM of Cascade. After translational and rotational alignment of a data set 
with  single  particle  projections,  sums  with  increasing  numbers  of  copies  in  equivalent 
positions show the gradual improvement in the signal-to-noise ratio.  (b) and (c) The two 
remaining classes of CasBCDE-DNA particles that are not depicted in Fig. 6. The number of 
particle projections to create the average shown is depicted on the bottom-right corner of each 
image. The § sign indicates that the depicted particle is a mirrored view of the original to 
match the predominant orientation of the Cascade projection shown in Fig. 6A. 
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Supplementary Fig. 9 
 
 
Interactions  between  individual  Cascade  subunits.  Composite  of  Coomassie  blue-stained 
SDS-polyacrylamide  gels  and  Western  blots  of  affinity  purified  tagged  Cascade  subunits 
(underlined)  co-expressed  with  untagged  Cascade  subunits  and  pre-crRNA.  All  subunits 
directly  interact  with  CasC  except  CasA,  which  interacts  with  CasE.  Western  blots  were 
probed with anti-Cascade antibodies. Note that the N-terminal Strep-tagged Cascade subunits 
migrate slower through the gel than the untagged proteins. 
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Supplementary Fig. 10 
 
 
 
Solution scattering model of Cascade obtained with Small-Angle X-ray Scattering. Scattering 
data for Cascade were collected at 10 keV (l = 1.24 Å) from two protein concentrations, and 
include scattering vectors (q), ranging from (a) 0.015 Å
-1 to 0.127 Å
-1 for Cascade and (b) 
0.015 Å
-1 to 0.133 Å
-1 for Cascade bound to target DNA. Guinier approximations of each 
curve estimates the radius of gyration (R(g)) for Cascade and for Cascade bound to target 
DNA at 5.6 nm. The pair-distribution function (insert) indicates that the radius of gyration for 
both particles is ~5.6 nm. (c) Ab initio reconstructions of Cascade reveal a seahorse shaped 
complex, consistent with EM imaging. (d) DNA binding induces a conformational change in 
Cascade. (e) Superposition of the solution structures of Cascade without (yellow) and with 
target DNA (mesh). Images have been rendered using Chimera
6. 
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Supplementary Table 1 
 
Exact masses of individual Cas protein subunits of Cascade. The masses of the Cascade (sub-) 
complexes observed under native mass spectrometry conditions are also listed. 
 
Cascade component  Theoretical Mass (Da)  Experimental Mass (Da) 
CasA  55,972.4  55,972.2 ± 14.8 
CasB with tag  21,260.4  21,261.5 ± 1.1 
CasB without tag  19,204.0  19,201.9 ± 1.8 
CasC  39,894.4  39,896.3 ± 1.3 
CasD  25,208.9  25,210.4 ± 3.8 
CasE  22,364.1  22,364.7 ± 1.1 
crRNA  19,660.8  19,708
a 
Complex  Theoretical Mass (Da)  Experimental Mass (Da) 
Cascade  405,095  405,365 ± 135 
Cascade without CasA  349,122  349,399 ± 84 
CasB dimer  42,521  42,524 ± 8 
 
a The mass of crRNA was indirectly calculated via tandem mass spectrometry analysis of CasE-crRNA. Since 
only dissociation products for CasE  were observed after collisional activation  no standard deviation can be 
calculated for the mass of crRNA. 
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Supplementary Table 2 
 
List  of  masses  for  all  Cascade  (sub)complexes  present  in  solution,  and  their  dissociated 
products that are formed in the gas phase after collisional activation during tandem mass 
spectrometry experiments. In addition for each complex the theoretical mass (based on amino 
acid sequence and a crRNA mass of 19,662 Da) and stoichiometric information is given. 
(A=CasA,  B=CasB,  C=CasC,  D=CasD,  E=CasE,  minus  (-)  indicates  the  lacking  subunit, 
n.d.is not determined. 
 
 
Mass of (sub) 
complexes in 
solution (Da) 
Mass 
products 
(Da) 
Theoretical 
mass  
(Da) 
                        Annotation 
 
Stoichiometry 
A  B  C  D  E  crRNA 
405,256    405,095  Cascade  1   2   6   1   1   1 
  365,316  365,200  Cascade-CasC  1   2   5   1   1   1 
  349,384  349,122  Cascade-CasA  0   2   6   1   1   1 
  55,950  55,972  CasA  1   0   0   0   0   0 
  39,941  39,894  CasC  0   0   1   0   0   0 
349,333    349,122  Cascade-CasA  0   2   6   1   1   1 
  324,389  323,914  Cascade-CasA-CasD  0   2   6   0   1   1 
  309,644  309,228  Cascade-CasA-CasC  0   2   5   1   1   1 
  270,031  269,334  Cascade-CasA-2·CasC  0   2   4   1   1   1 
  39,946  39,894  CasC  0   0   1   0   0   0 
  25,231  25,209  CasD  0   0   0   1   0   0 
306,932    306,602  Cascade-CasA-2·CasB  0   0   6   1   1   1 
  281,915  281,393  Cascade-CasA-2·CasB-CasD  0   0   6   0   1   1 
  267,215  266,707  Cascade-CasA-2·CasB-CasC  0   0   5   1   1   1 
  227,267  226,813  Cascade-CasA-2·CasB-2·CasC  0   0   4   1   1   1 
  39,935  39,894  CasC  0   0   1   0   0   0 
  25,250  25,209  CasD  0   0   0   1   0   0 
267,076    266,707  Cascade-CasA-2·CasB-CasC  0   0   5   1   1   1 
  241,503  241,498  Cascade-CasA-2·CasB-CasC-CasD  0   0   5   0   1   1 
  226,673  226,813  Cascade-CasA-2·CasB-2·CasC  0   0   4   1   1   1 
  39,928  39,894  CasC  0   0   1   0   0   0 
  25,227  25,209  CasD  0   0   0   1   0   0 
227,127    226,813  Cascade-CasA-2·CasB-2·CasC  0   0   5   1   1   1 
  202,019  201,604  Cascade-CasA-2·CasB-2·CasC-CasD  0   0   4   0   1   1 
  187,241  186,918  Cascade-CasA-2·CasB-3·CasC  0   0   3   1   1   1 
  39,946  39,894  CasC  0   0   1   0   0   0 
187,352    186,918  Cascade-CasA-2·CasB-3·CasC  0   0   3   1   1   1 
  161,882  161,710  Cascade-CasA-2·CasB-3·CasC-CasD  0   0   3   0   1   1 
  147,087  147,024  Cascade-CasA-2·CasB-4·CasC  0   0   2   1   1   1 
  39,910  39,894  CasC  0   0   1   0   0   0 
  25,218  25,209  CasD  0   0   0   1   0   0 
147,210    147,024  Cascade-CasA-2·CasB-4·CasC  0   0   2   1   1   1 
  121,869  121,815  Cascade-CasA-2·CasB-4·CasC-CasD  0   0   2   0   1   1 
  n.d.  107,130  Cascade-CasA-2·CasB-5·CasC  0   0   1   1   1   1 
  39,916  39,894  CasC  0   0   1   0   0   0 
  25,219  25,209  CasD  0   0   0   1   0   0 
107,431    107,130  Cascade-CasA-2·CasB-5·CasC  0   0   1   1   1   1 
  84,696  84,766  Cascade-CasA-2·CasB-5·CasC-CasE  0   0   1   1   0   1 
  22,375  22,364  CasE  0   0   0   0   1   0 
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Supplementary Table 3 
 
Strains, plasmids and primers used in this study 
 
Strains  Description  Source 
E.coli BL21(DE3)  F
- ompT gal dcm lon hsdSB(rB -mB -) λ(DE3 [lacI lacUV5-T7 gene 1 ind1 sam7 nin5])  Novagen 
E.coli BL21-AI  F
- ompT gal dcm lon hsdSB(rB -mB -) araB::T7RNAP-tetA   Invitrogen 
E.coli NEB5α  fhuA2 _(argF-lacZ)U169 phoA glnV44 Φ80_ (lacZ)M15 gyrA96 recA1 relA1 endA1 thi-1 hsdR17  New England Biolabs 
E.coli DH5α  F
- endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR nupG Φ80dlacZ M15  (lacZYA-argF)U169, hsdR17(rK -mK +), λ–    
 
Plasmids  Description and order of genes (5’-3’)  Restriction sites  Primers  Source 
pET-52b(+)   T7 RNA polymerase based expression vector, Amp
R       Novagen  
pRSF-1b   T7 RNA polymerase based expression vector, Kan
R       Novagen  
pCDF-1b   T7 RNA polymerase based expression vector, Str
R       Novagen  
pACYCduet-1   T7 RNA polymerase based expression vector, Cam
R       Novagen  
pWUR381  cas3 in pET-52b with both Strep-tag II (N-term) and His10-tag (C-term)  BamHI/NotI  BG2243 + BG2244  This study 
pWUR388  casA in pET-52b with both Strep-tag II (N-term) and His10-tag (C-term)     
1 
pWUR396   E. coli K12 CRISPR in pACYCDuet-1, see Fig S2      
1 
pWUR397   cas3 in pRSF-1b, no tags      
1 
pWUR400   casA-casB-casC-casD-casE in pCDF-1b, no tags      
1 
pWUR401   casB-casC-casD-casE in pCDF-1b, no tags      
1 
pWUR402   casC-casD-casE in pCDF-1b, no tags      
1 
pWUR403   casD-casE in pCDF-1b, no tags      
1 
pWUR404   casE in pCDF-1b, no tags      
1 
pWUR405   casA-casB-casC-casD in pRSF-1b, no tags      
1 
pWUR406   casA-casB-casC in pRSF-1b, no tags      
1 
pWUR407   casA-casB in pRSF-1b, no tags      
1 
pWUR408   casA in pRSF-1b, no tags      
1 
pWUR413  casD in pRSF-1b, no tags  NcoI/NotI  BG2466 + BG2482  This study 
pWUR477   non targeting CRISPR in pACYCDuet-1 (N), see Fig S2     
1 
pWUR478   template CRISPR in pACYCDuet-1 (T1-4), see Fig S2     
1 
pWUR479   coding CRISPR in pACYCDuet-1 (C1-4)      
1 
pWUR480   casB with Strep-tag II (N-term)-casC-casD in pET52b      
1 
pWUR482  casE in pET52-1b, with Strep-tag II (N-term)  BamHI/NotI  BG2586 + BG2253  This study 
pWUR514  casB with Strep-tag II (N-term)-casC-casD-CasE in pET52b  Acc65I/NotI  BG2573 + BG2586  This study 
pWUR547  E. coli R44 CRISPR, 7x spacer nr. 2, in pACYCDuet-1, see Fig S2  EcoNI/Acc65I   
4, Geneart, Germany 
pWUR553  casB in pET52-1b, with Strep-tag II (N-term)  Acc65I/NotI  BG2573 + BG2484  This study 
pWUR554  casC in pCDF-1b, no tags  NcoI/NotI  BG2465 + BG2483  This study 
pWUR555  casC in pET52-1b, with Strep-tag II (N-term)  BamHI/NotI  BG2249 + BG2483  This study 
pWUR613  pUC19 containing R44-protospacer on a 350 bp phage P7 amplicon  BamHI/HindIII  BG3297 + BG3298  This study 
 
Experiment  Primer  Sequence (5’-3’)  Description 
BG2243  GCGCGGGATCCTATGGAACCTTTTAAATATATATGCC   cas3 + BamHI (fw) 
BG2244  GGCCCGCGGCCGCTTTGGGATTTGCAGGGATGACT   cas3 + NotI (rv) 
BG2249  GCGCGGGATCCTATGTCTAACTTTATCAATATTCATGT   casC + BamHI (fw) 
BG2253  GCGCGGGATCCTATGTATCTCAGTAAAGTCATCATTG   casE + BamHI (fw) 
BG2316  GCGCGGGTACCAGATGAGATCTTATTTGATCTTGCGG   casD + Acc65I (fw) 
BG2465  GCGCGCCATGGCTATGTCTAACTTTATCAATATTCATGT  casC + NcoI (fw) 
BG2466  GCGCGCCATGGCTATGAGATCTTATTTGATCTTGCGG  casD + NcoI (fw) 
BG2482  GGCCCGCGGCCGCTTACTGAGATACATCCATACCTCC  casD + NotI (rv) + stopcodon 
BG2483  GGCCCGCGGCCGCTCACGCCTCGCCATTATTACGA  casC +NotI (rv) + stopcodon 
BG2484  GGCCCGCGGCCGCTTACGCATTTTTGTTTGTGGTCAAT  casB + NotI (rv) + stopcodon 
BG2573  GCGCGGGTACCAGATGGCTGATGAAATTGATGCAATG  casB + Acc65I (fw) 
BG2586  GGCCCGCGGCCGCCTGCAGTCACAGTGGAGCCAAAGATAGCAAG  casE + NotI (rv) + stopcodon 
BG3048  GCGCGGAATTCATGAGATCTTATTTGATCTTGCGG  casD + EcoRI (fw) 
BG3049  GGCCCCTGCAGTTACTGAGATACATCCATACCTCC  casD + PstI + stopcodon (rv) 
BG3297  GGCCCGGATCCCCAATACAGCGATCAACGCCTTC  phage P7 fragment + BamHI (fw) 
Cloning 
BG3298  CGCGCAAGCTTCGATGCTGATGGGGATTAACAG  phage P7 fragment + HindIII (rv) 
BG3009  AAGCTGATCGGCAAGCTCGAAAGCACGACGGTATTGTTCAGATCCTGGCTTGCCAACAGTG
ATTTGCTCAATTTTGTAGATTGAAG 
Target with R44 protospacer, and 
flanking sequences
1 
BG3010  CTTCAATCTACAAAATTGAGCAAATCACTGTTGGCAAGCCAGGATCTGAACAATACCGTCG
TGCTTTCGAGCTTGCCGATCAGCTT 
Target with R44 protospacer, and 
flanking sequences
2 
BG3011  AAGCTGATCGGCAAGCTCGAAAGCACGTTGACTTGGATCACCGACCTTGGCGATTACGATG
ATTTGCTCAATTTTGTAGATTGAAG 
Target with scrambled R44 
protospacer and flanking sequences
1 
BG3012  CTTCAATCTACAAAATTGAGCAAATCATCGTAATCGCCAAGGTCGGTGATCCAAGTCAACG
TGCTTTCGAGCTTGCCGATCAGCTT 
Target with scrambled R44 
protospacer and flanking sequences
2 
BG3032  ACGGTATTGTTCAGATCCTGGCTTGCCAACAG  Target with R44 protospacer, 
without flanking sequences
1 
EMSA 
BG3033  CTGTTGGCAAGCCAGGATCTGAACAATACCGT  Target with R44 protospacer, 
without flanking sequences
2 
BG3030  CCATGGTAATACGACTCACTATAGGGCTTCAATCTACAAAATTGAGCAA  T7 promoter primer to generate a 
template for in vitro transcription 
3 
BG3031  AAGCTGATCGGCAAGCTCGAAAGC  Primer to generate a template for in 
vitro transcription
3 
BG3079  CCATGGTAATACGACTCACTATAGGGAAGCTGATCGGCAAGCTCGAAAG  T7 promoter primer to generate a 
template for in vitro transcription 
3 
In vitro 
transcription  
(to generate RNA 
products for 
EMSA) 
BG3080  CTTCAATCTACAAAATTGAG  Primer to generate a template for in 
vitro transcription
3 
ESI-MS 
Native PAGE 
EM 
BG3028   biotin-TEG-CTGTTGGCAAGCCAGGATCTGAACAATACCGT  R44 protospacer (A) 
1 DNA sequence corresponds to crRNA sequence, 
2 DNA sequence complementary to crRNA sequence, 
3 These primers were used to prepare material for in vitro transcription by PCR by 
adding on a T7 promoter, using either BG3009-BG3010 or BG3011-BG3012 as template. Restriction sites are underlined, Proto-spacer sequences are in bold. 
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Mass Spectrometry analysis of RNase digests. RNaseT1 and RNaseA digests of mature 
crRNA  was  performed  using  an  ESI-MS/MS  using  a  HCT  Esquire  Quadruple  Ion  Trap 
(Bruker Daltonics) coupled to a Dionex. The oligoribonucleotide mixture was separated on a 
PepMap C-18 RP capillary column (300 mm ´ 150 mm I.D., Dionex, UK) at 50 
°C using a 
gradient  condition  starting  at  20%  buffer  D  (0.4  M  1,1,1,3,3,3,-Hexafluoro-2-propanol 
(Sigma-Aldrich)  adjusted  with  triethylamine  (TEA)  to  pH  7.0,  0.1  mM  TEAA,  and  50% 
methanol (v/v) (Fisher)) and extending to 35% D in 20 min at a flow rate of 2  l /min. The 
mass spectrometer was set select a mass range of 250−1500 m/z and the capillary voltage was 
kept at -3650 V. Oligoribonucleotides with -2 to -4 charge states were selected for tandem 
mass spectrometry using collision induced dissociation. The theoretical masses of the crRNA 
and predicted digests were determined using the Mongo Oligo Mass Calculator. 
 
Electrophoretic Mobility Shift Assays. DNA targets were gel-purified long oligonucleotides 
(Isogen Life Sciences or Biolegio), listed in Supplementary Table 3. The oligonucleotides 
were end-labeled using γ
32P-ATP (PerkinElmer) and T4 kinase (Fermentas). Double-stranded 
DNA  targets  were  prepared  by  annealing  complementary  oligonucleotides  and  digesting 
remaining  ssDNA  with  Exonuclease  I  (Fermentas).  Labeled  RNA  targets  were  in  vitro 
transcribed  using  T7  Maxiscript  or  T7  Mega  Shortscript  kits  (Ambion)  with  α
32P-CTP 
(PerkinElmer)  and  removing  template  by  DNaseI  (Fermentas)  digestion.  Double  stranded 
RNA targets were prepared by annealing complementary RNAs and digesting surplus ssRNA 
with RNaseT1 (Fermentas), followed by phenol extraction. 
  Plasmid  mobility  shift  assays  were  performed  using  plasmid  pWUR613 
(Supplementary  Table  3)  containing  the  R44  protospacer.  The  fragment  containing  the 
protospacer was PCR-amplified from bacteriophage P7 genomic DNA using primers BG3297 
and BG3298 (Supplementary Table 3). Plasmid (0.4 µg) and Cascade were mixed in a 1:10 
molar ratio and incubated at 37 °C for 30 minutes. Cascade proteins were then removed by 
proteinase  K  treatment  (Fluka)  (0.15  U,  15  min,  37  °C)  and  PCI  extraction.  RNA-DNA 
complexes were then treated with RNaseH (Promega) (2 U, 1 h, 37 °C). 
 
Electron Microscopy data analysis. Approximately 400,000 single particles were selected 
and extracted from 17,000 electron micrographs. Single particle data sets were analyzed with 
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GRIP software
7 using multi-reference alignments and no-reference alignments, multivariate 
statistical  analysis,  and  hierarchical  ascendant  classification.  The  final  two-dimensional 
projection maps were calculated from the best resolved classes by summing the best 5–20% 
of the projections based on the correlation coefficient determined in the alignment step. 
 
Western  blotting.  The  purified  proteins  transferred  to  nitrocellulose  membrane  (Perkin-
Elmer), and incubated for 1 h in Phosphate Buffered Saline (PBS) blocking buffer pH 7.5, 
supplemented with 0.1% Tween 20 and 5% milk powder. The membranes were incubated 
with anti-Cascade serum raised in rabbits (Eurogentec, Belgium) (1:1000) in blocking buffer 
for 12 h, followed by three 15 min wash steps in PBS supplemented with 0.1% Tween 20. 
The membrane was then incubated with HRP-conjugated anti-rabbit antibodies (GE) (1:5000) 
in wash buffer for 1 h, followed by three 15 min wash steps. Photographic film detection 
(KODAK) of the signal was performed using ECL-plus substrate (GE). 
 
Small-Angle  X-ray  Scattering.  Data  were  collected  at  the  Advanced  Light  Source 
(Lawrence Berkeley National Laboratory) on beamline 7.3.3. Solution scattering of Cascade 
was  collected  at  room  temperature  (~22  °C)  using  at  least  two  different  concentrations 
(between 1 mg/ml and 18 mg/ml) in a 20 µl sample at 10 keV (l = 1.24 Å). The sample-to-
detector distance was set to 3056.69 mm resulting in scattering vectors (q) ranging from 0.012 
Å
-1  to  0.127  Å
-1.  Scatter  plots  for  the  low  and  high  concentrations  were  merged  and 
background  subtracted  using  PRIMUS
8.  One-dimensional  scatter  curves  were  transformed 
and distance distribution functions P(r) were calculated using GNOM
9. The pair-distribution 
function P(r), the frequency of interatomic vector lengths within the scattering particle, was 
calculated  from  the  entire  scattering  curve  I(q),  by  an  indirect  Fourier  transform  using 
GNOM.  Ten  independent  models  were  generated  using  a  simulated  annealing  method  in 
DAMMIF
10. Ab initio reconstructions were aligned, filtered and averaged based on occupancy 
using DAMAVER
11. The SAXS bead models were converted to volumetric format using the 
pdb2vol convolution kernel in the Situs software package
12. Volumes were calculated using 
VOIDOO
13. 
Nature Structural & Molecular Biology: doi:10.1038/nsmb.2019 
 
References 
 
 
1.  Brouns, S.J. et al. Small CRISPR RNAs guide antiviral defense in prokaryotes. 
Science 321, 960-4 (2008). 
2.  Barrick, J.E. et al. Genome evolution and adaptation in a long-term experiment with 
Escherichia coli. Nature 461, 1243-7 (2009). 
3.  Ochman, H. & Selander, R.K. Standard reference strains of Escherichia coli from 
natural populations. J Bacteriol 157, 690-3 (1984). 
4.  Mojica, F.J., Diez-Villasenor, C., Garcia-Martinez, J. & Soria, E. Intervening 
sequences of regularly spaced prokaryotic repeats derive from foreign genetic 
elements. J Mol Evol 60, 174-82 (2005). 
5.  Zaug, A.J., Linger, J. & Cech, T.R. Method for determining RNA 3' ends and 
application to human telomerase RNA. Nucleic Acids Res 24, 532-3 (1996). 
6.  Goddard, T.D., Huang, C.C. & Ferrin, T.E. Software extensions to UCSF Chimera for 
interactive visualization of large molecular assemblies. Structure 13, 473-482 (2005). 
7.  van Heel, M. et al. Single-particle electron cryo-microscopy: towards atomic 
resolution. Quarterly Reviews of Biophysics 33, 307-369 (2000). 
8.  Konarev, P.V., Volkov, V.V., Sokolova, A.V., Koch, M.H.J. & Svergun, D.I. 
PRIMUS: a Windows PC-based system for small-angle scattering data analysis. 
Journal of Applied Crystallography 36, 1277-1282 (2003). 
9.  Svergun, D.I. Determination of the Regularization Parameter in Indirect-Transform 
Methods Using Perceptual Criteria. Journal of Applied Crystallography 25, 495-503 
(1992). 
10.  Franke, D. & Svergun, D.I. DAMMIF, a program for rapid ab-initio shape 
determination in small-angle scattering. Journal of Applied Crystallography 42, 342-
346 (2009). 
11.  Volkov, V.V. & Svergun, D.I. Uniqueness of ab initio shape determination in small-
angle scattering. Journal of Applied Crystallography 36, 860-864 (2003). 
12.  Wriggers, W., Milligan, R.A. & McCammon, J.A. Situs: A package for docking 
crystal structures into low-resolution maps from electron microscopy. Journal of 
Structural Biology 125, 185-195 (1999). 
13.  Kleywegt, G.J. & Jones, T.A. Detection, delineation, measurement and display of 
cavities in macromolecular structures. Acta Crystallogr D Biol Crystallogr 50, 178-85 
(1994). 
 
 
Nature Structural & Molecular Biology: doi:10.1038/nsmb.2019